SCM
Silverarc Capital Management Portfolio holdings
AUM
$691M
1-Year Est. Return
223.03%
1 Year Est. Return
+223.03%
AUM
$489M
AUM Growth
+$9.97M
(+2.1%)
Holding
83
Top Buys
| 1 | +$14.1M | |
| 2 | +$12.1M | |
| 3 | +$11.4M | |
| 4 |
Vaxcyte
PCVX
|
+$9.36M |
| 5 |
UroGen Pharma
URGN
|
+$8.79M |
Top Sells
| 1 | +$17.7M | |
| 2 | +$15.5M | |
| 3 | +$11.7M | |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$8.49M |
| 5 |
Wave Life Sciences
WVE
|
+$8.49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merus
MRUS
$7.28B
| $39M | 7.2% |
741,972
-69,049
|
|
||
2
Akero Therapeutics
AKRO
$4.47B
| $38.1M | 7.02% |
713,811
-6,181
|
|
||
|
VRNA
3
DELISTED
Verona Pharma
VRNA
| $33.9M | 6.25% |
358,297
-187,575
|
|
||
|
4
UroGen Pharma
URGN
$1.11B
| $27.7M | 5.11% |
2,022,482
+641,324
|
|
||
5
Rhythm Pharmaceuticals
RYTM
$6.63B
| $25.3M | 4.67% |
400,772
+63,167
|
|
||
6
Insmed
INSM
$41.2B
| $25.1M | 4.62% |
249,060
-72,306
|
|
||
7
KalVista Pharmaceuticals
KALV
$688M
| $20.7M | 3.82% |
1,832,171
+133,187
|
|
||
8
Neurocrine Biosciences
NBIX
$14.4B
| $20.5M | 3.78% |
162,969
+90,386
|
|
||
|
ETNB
9
DELISTED
89bio
ETNB
| $20M | 3.69% |
2,037,087
+526,589
|
|
||
10
Oric Pharmaceuticals
ORIC
$1.19B
| $18.3M | 3.37% |
1,800,829
-259,411
|
|
||
11
Nuvalent
NUVL
$7.02B
| $18M | 3.31% |
235,583
-203,435
|
|
||
12
Soleno Therapeutics
SLNO
$2.65B
| $17.1M | 3.16% |
204,591
+38,174
|
|
||
13
Ascendis Pharma
ASND
$12.5B
| $14.9M | 2.75% |
86,552
+10,801
|
|
||
14
CG Oncology
CGON
$3.13B
| $14.1M | 2.59% |
+541,034
|
|
||
15
Veracyte
VCYT
$3.11B
| $12.1M | 2.24% |
448,495
-185,337
|
|
||
16
Scholar Rock
SRRK
$3.6B
| $12.1M | 2.23% |
+341,010
|
|
||
17
Avidity Biosciences
RNA
$10.7B
| $11.6M | 2.15% |
410,000
-1,312
|
|
||
|
18
Vaxcyte
PCVX
$6.37B
| $9.36M | 1.73% |
+287,796
|
|
||
19
Pfizer
PFE
$142B
| $8.35M | 1.54% |
+344,338
|
|
||
|
BBOT
20
BridgeBio Oncology
BBOT
$1.05B
| $6.51M | 1.2% |
613,393
|
|
||
21
Gossamer Bio
GOSS
$627M
| $6.33M | 1.17% |
5,146,782
-1,173,902
|
|
||
|
MTSR
22
DELISTED
Metsera Inc
MTSR
| $5.91M | 1.09% |
207,581
+94,822
|
|
||
23
Elutia
ELUT
$31.6M
| $5.47M | 1.01% |
2,761,684
+91,628
|
|
||
24
Compugen
CGEN
$153M
| $5.4M | 1% |
3,033,879
+138,449
|
|
||
25
TELA Bio
TELA
$40.3M
| $5.39M | 0.99% |
2,779,795
+8,507
|
|